CD14 and type 2 diabetes mellitus: Hence, this study aims to elucidate whether circulating monocyte subsets, especially CD14++CD16+ monocytes, are associated with serum fetuin-A levels and their related insulin resistance in patients with type 2 diabetes mellitus (T2D).